M. H. Pahus

Most-cited papers

1. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

   J. Gunst, N. B. Staerke, M. H. Pahus, L. H. Kristensen +35 more

   2021EClinicalMedicine161 citations Open access

   Semantic Scholar

   Save

2. Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

   J. Gunst, M. H. Pahus, Míriam Rosás-Umbert, I-Na Lu +29 more

   2022Nature Medicine135 citations Open access

   Semantic Scholar

   Save

3. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

   Line K. Vibholm, S. Nielsen, M. H. Pahus, Giacomo S. Frattari +13 more

   2021EBioMedicine120 citations Open access

   Semantic Scholar

   Save

4. Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

   J. Gunst, J. F. Højen, M. H. Pahus, Míriam Rosás-Umbert +29 more

   2023Nature Medicine84 citations Open access

   Semantic Scholar

   Save

5. Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

   Míriam Rosás-Umbert, J. Gunst, M. H. Pahus, R. Olesen +18 more

   2022Nature Communications75 citations Open access

   Semantic Scholar

   Save

6. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

   S. Nielsen, Line K. Vibholm, Ida Monrad, R. Olesen +11 more

   2020bioRxiv64 citations Open access

   Semantic Scholar

   Save

7. The impact of 3BNC117 and romidepsin on the HIV-1 reservoir in individuals on suppressive antiretroviral therapy (ROADMAP): a phase 2a randomized clinical trial

   H. Gruell, J. Gunst, Yehuda Z. Cohen, M. H. Pahus +21 more

   2022The Lancet Microbe55 citations Open access

   Semantic Scholar

   Save

8. Effect of Age on Innate and Adaptive Immunity in Hospitalized COVID-19 Patients

   Lamin B. Cham, M. H. Pahus, Kristoffer Grønhøj, R. Olesen +6 more

   2021Journal of Clinical Medicine13 citations Open access

   Semantic Scholar

   Save

9. Evaluation and real-world experience of a neutralization susceptibility screening assay for broadly neutralizing anti-HIV-1 antibodies.

   M. H. Pahus, Yu Zheng, Maxine Olefsky, J. Gunst +9 more

   2024Journal of Infectious Diseases8 citations Open access

   Semantic Scholar

   Save

10. Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control

    K. Fisher, Mauro A. Garcia, Giacomo S. Frattari, C. Naasz +38 more

    2026Nature Immunology7 citations Open access

    Semantic Scholar

    Save

11. CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy

    Stine Sofie Frank Lende, M. H. Pahus, Ida Monrad, R. Olesen +7 more

    2022Frontiers in Cellular and Infection Microbiology6 citations Open access

    Semantic Scholar

    Save

12. HIV-1 acquisition in a man with ulcerative colitis on anti-α4β7 mAb vedolizumab treatment.

    J. Gunst, M. Schleimann, M. H. Pahus, L. Østergaard +2 more

    2020AIDS (London)1 citations Open access

    Semantic Scholar

    Save